Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy
NCT05166109Phase 2Completed
- Sponsor
- ReveraGen BioPharma
- Start
- Jul 2022
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of vamorolone in Becker muscular dystrophy (BMD), sponsored by ReveraGen BioPharma. Started Jul 2022; status: completed.
02
Drugs
vamorolone
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT05166109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05166109.